Efficacy of Compound Betamethasone Injection Combined With Ropivacaine in Ultrasound-guided Thoracic Paravertebral Nerve Block for Chronic Post-thoracotomy Pain

Sponsor
Affiliated Hospital of Nantong University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05175001
Collaborator
(none)
100
1
2
21
4.8

Study Details

Study Description

Brief Summary

Chronic post-thoracotomy pain(CPTP)will not only have a negative impact on patients' physiology and psychology, but also affect postoperative recovery.A number of researches have demonstrated that Injury to the intercostal nerve during surgery predominantly accounts for the onset of CPTP.It is closely related to postoperative local acute inflammation and neuroinflammation. Thoracic paravertebral block (TPVB)has become a new trend for post-thoracotomy pain management.Glucocorticoids,as a adjuvant, are reported to prolong the effects of local anesthetic for peripheral nerve blocks.Diprospan is a long-acting glucocorticoid. It has been widely used in clinical treatment of various pain syndromes for powerful analgesic and anti-inflammatory effects. At present, most clinical reports are limited to the acute postoperative period, and there are few studies focusing on the long-term postoperative analgesic effect of diprospan.Therefore, it is reasonable for us to hypothesise diprospan, as a longer-acting glucocorticoid, can provide more lasting analgesic effects,or even reduce the incidence of CPTP

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

PARAVERTEBRAL BLOCK (PVB) involves the injection of local anesthetic (LA) into a wedge-shaped space lateral to the spinal nerves as they emerge from the intervertebral foramina, producing ipsilateral somatosensory and sympathetic nerve blockade.Since its initial application in abdominal surgery, the technique has been adapted for rib fracture, flflail chest, open cholecystectomy, hepatic-biliary surgery, outpatient inguinal hernia repair, major breast cancer surgery, and open thoracotomy patient populations.Based on several recent systematic reviews and metaanalyses,TPVB and TEA are equal in analgesic effect after thoracic surgery. Moreover, TPVB is associated with fewer side effects,such as urinary retention,nausea/vomiting,pruritus and hypotension. It can also be used for patients with coagulation disorders. Kang et al. argued that TPVB can significantly improve postoperative rehabilitation in patients undergoing thoracoscopic radical lung cancer surgery .

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The patient is placed in lateral decubitus position with the operative side facing up, and the thoracic paravertebral nerve block will be performed under ultrasound. We select T4-5,T6-7and T8-9 intervertebral spaces for puncture.The patient is placed in lateral decubitus position with the operative side facing up, and the thoracic paravertebral nerve block will be performed under ultrasound. We select T4-5,T6-7and T8-9 intervertebral spaces for puncture.
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Masking Description:
None of the participants know which group they were in,neither of the investigators and outcomes assessor.
Primary Purpose:
Prevention
Official Title:
Efficacy of Compound Betamethasone Injection Combined With Ropivacaine in Ultrasound-guided Thoracic Paravertebral Nerve Block for Chronic Post-thoracotomy Pain
Actual Study Start Date :
May 1, 2021
Anticipated Primary Completion Date :
Jun 30, 2022
Anticipated Study Completion Date :
Jan 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Group R

The patient is placed in lateral decubitus position with the operative side facing up, and the thoracic paravertebral nerve block will be performed under ultrasound. We select T4-5,T6-7and T8-9 intervertebral spaces for puncture.A 30-mL bolus of a solution of 0.33% ropivacaine in saline was administered under real-time ultrasound monitoring

Drug: Ropivacaine
Only ropivacaine in ultrasound-guided thoracic paravertebral nerve block

Experimental: Group RD

The patient is placed in lateral decubitus position with the operative side facing up, and the thoracic paravertebral nerve block will be performed under ultrasound. We select T4-5,T6-7and T8-9 intervertebral spaces for puncture.A 30-mL bolus of a solution of 0.33% ropivacaine plus 4.67mg Diprospan in saline was administered under real-time ultrasound monitoring

Drug: Diprospan
Diprospan combined with ropivacaine in ultrasound-guided thoracic paravertebral nerve block
Other Names:
  • Compound Betamethasone Injection
  • Outcome Measures

    Primary Outcome Measures

    1. Acute and chronic postoperative pain [24 hours after surgery]

      Numeric rating scale(NRS) is used to assess acute postoperative pain

    2. Acute and chronic postoperative pain [48 hours after surgery]

      Numeric rating scale(NRS) is used to assess acute postoperative pain

    3. Acute and chronic postoperative pain [72 hours after surgery]

      Numeric rating scale(NRS) is used to assess acute postoperative pain

    4. Acute and chronic postoperative pain [1 month after surgery]

      Numeric rating scale(NRS) is used to assess chronic postoperative pain

    5. Acute and chronic postoperative pain [3 months after surgery]

      Numeric rating scale(NRS) is used to assess chronic postoperative pain

    6. Acute and chronic postoperative pain [6 months after surgery]

      Numeric rating scale(NRS) is used to assess chronic postoperative pain

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Aged 18-70 years

    2. American Society of Anesthesiologists(ASA) physical status of I-III

    3. BMI: 18.5-28 kg/m2

    4. Type of operation: elective thoracoscopic lobectomy

    5. The patient and/or family members have signed the informed consent -

    Exclusion Criteria:
    1. Allergic to local anesthetics or glucocorticoids

    2. Preoperative use of opioids

    3. Severe coagulation dysfunction

    4. Severe heart, lung, liver and kidney insufficiency

    5. Used to have immunosuppressive therapies such as radiotherapy, chemotherapy and glucocorticoid, or have immune system diseases

    6. Peptic ulcer

    7. Perform astrointestinal anastomosis recently

    8. Used to have a chest surgery

    9. Central nervous system disease or peripheral neuropathy

    10. Perioperative blood transfusion

    11. Others: such as fracture, wound repair, corneal ulcer, adrenal hypercortical disease, diabetes, pregnant women -

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Affiliated Hospital of Nantong University Nantong Jiangsu China 226000

    Sponsors and Collaborators

    • Affiliated Hospital of Nantong University

    Investigators

    • Study Director: Yibin Qin, Associate chief physician, Affiliated Hospital of Nantong University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Yibin Qin, Associate chief physician, Affiliated Hospital of Nantong University
    ClinicalTrials.gov Identifier:
    NCT05175001
    Other Study ID Numbers:
    • AHNantongUniversity
    First Posted:
    Jan 3, 2022
    Last Update Posted:
    Mar 2, 2022
    Last Verified:
    Mar 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Yibin Qin, Associate chief physician, Affiliated Hospital of Nantong University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 2, 2022